Lionco Pharmaceutical Group Co.,Ltd. Posted 69.7 Million Yuan Net Loss in First Half of 2023

Lionco Pharmaceutical Group Co.,Ltd. (灵康药业集团股份有限公司) (603669.SH) reported a net loss of 69.7 million yuan in the first half of 2023, reversing a net profit of 35.9 million yuan for the same period in the previous year.

Meanwhile, the company posted 112.9 million yuan in revenue, down 43.6% year-on-year.

At the end of the reporting period, it had 1.8 billion yuan in total assets and 736 million yuan in total liabilities, with a liability-to-asset ratio of 40.9%.